Join
Live feed
·
INSIDERFilingvia Quantisnow
Definium Therapeutics Inc. logo

Chief Executive Officer Barrow Robert was granted 375,000 shares, increasing direct ownership by 34% to 1,473,246 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
DFTX· Definium Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DFTX (Definium Therapeutics Inc.) and more on Quantisnow.